Shenzhen Yifeng Investment Management Enterprise Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
13
- Investments
-
170
- Portfolio
-
98
- Exits
-
43
Shenzhen Yifeng Investment Management Enterprise General Information
Company Description
Founded in 2007, Efung Capital is a venture capital firm based in Shenzhen, China. The firm seeks to invest in the healthcare and life science sectors.
Business Details
Website
en.efungcapital.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 58th Floor, Tower 2, Huanggang Business Center
- Number 2028 Jintian Road, Futian District
- Shenzhen, Guangdong
- China
Shenzhen Yifeng Investment Management Enterprise Investments (170)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Ruichu | 21-Oct-2026 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| Xinyun Life Science | 24-Aug-2026 | Diagnostic Equipment | Generating Revenue | |||
| Renerval Therapeutics | 07-Aug-2026 | Biotechnology | Generating Revenue | |||
| Xgene Pharmaceutical | 28-Jul-2026 | Drug Discovery | Generating Revenue | |||
| Byterna Therapeutics | 22-Jul-2026 | Drug Discovery | Generating Revenue | |||
| Delova Biotech | 21-Jul-2026 | Drug Discovery | Generating Revenue | |||
| Pinshan Biotechnology | 19-Jul-2026 | Discovery Tools (Healthcare) | Generating Revenue | |||
| TanShengWanWu | 12-Jun-2026 | Alternative Energy Equipment | Generating Revenue | |||
| Barty Medical | 09-Jun-2026 | Later Stage VC | Surgical Devices | Generating Revenue | ||
| Vivolight Medical | 27-May-2026 | Later Stage VC | Surgical Devices | Generating Revenue |
Shenzhen Yifeng Investment Management Enterprise Exits (43)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Zhuhai Trinomab Pharmaceutical | 21-Jul-2026 | IPO | |
| Centrexion Therapeutics | 01-Apr-2026 | ||
| Insight Lifetech | 05-Feb-2026 | ||
| Healthgen Biotech | 28-Oct-2025 | ||
| Xuanzhu Biopharm | 15-Oct-2025 | ||
| LumiThera | 02-Sep-2025 | ||
| Raynovent | 31-Jul-2025 | ||
| CirCode | 15-Jul-2025 | ||
| Cloudbreak Pharma | 03-Jul-2025 | IPO | |
| Xuanzhu Biopharm | 15-Nov-2024 | Secondary Transaction - Private |
Shenzhen Yifeng Investment Management Enterprise Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Shenzhen Yifeng Investment Management Enterprise Co-Investors (188)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| HSG (Hong Kong) | 4 |
|
|
||
| Shenzhen GTJA Investment Group |
|
|
|||
| Cowin Capital |
|
|
|||
| Shenzhen CDF Capital |
|
|
|||
| Suzhou Oriza Holdings Corporation |
|
|
Shenzhen Yifeng Investment Management Enterprise FAQs
-
What is Shenzhen Yifeng Investment Management Enterprise?
Founded in 2007, Efung Capital is a venture capital firm based in Shenzhen, China.
-
When was Shenzhen Yifeng Investment Management Enterprise founded?
Shenzhen Yifeng Investment Management Enterprise was founded in 2007.
-
Where is Shenzhen Yifeng Investment Management Enterprise headquartered?
Shenzhen Yifeng Investment Management Enterprise is headquartered in Shenzhen, China.
-
How many investments has Shenzhen Yifeng Investment Management Enterprise made?
Shenzhen Yifeng Investment Management Enterprise has made 170 investments.
-
What has Shenzhen Yifeng Investment Management Enterprise invested in?
Shenzhen Yifeng Investment Management Enterprise has made numerous investments in companies like Ruichu, Xinyun Life Science, and Renerval Therapeutics within the Drug Discovery, Diagnostic Equipment, and Biotechnology industries.
-
What has Shenzhen Yifeng Investment Management Enterprise invested in recently?
Shenzhen Yifeng Investment Management Enterprise's latest investment was on 21-Oct-2026 in Ruichu, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
